FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984156843> ?p ?o ?g. }

• W1984156843 endingPage "e111115" @default.
• W1984156843 startingPage "e111115" @default.
• W1984156843 abstract "The long term effects of fingolimod, an oral treatment for relapsing-remitting (RR) multiple sclerosis (MS), on blood circulating B and T cell subtypes in MS patients are not completely understood. This study describes for the first time the longitudinal effects of fingolimod treatment on B and T cell subtypes. Furthermore, expression of surface molecules involved in antigen presentation and costimulation during fingolimod treatment are assessed in MS patients in a 12 month follow-up study.Using flow cytometry, B and T cell subtypes, and their expression of antigen presentation, costimulation and migration markers were measured during a 12 month follow-up in the peripheral blood of MS patients. Data of fingolimod-treated MS patients (n = 49) were compared to those from treatment-naive (n = 47) and interferon-treated (n = 27) MS patients.In the B cell population, we observed a decrease in the proportion of non class-switched and class-switched memory B cells (p<0.001), both implicated in MS pathogenesis, while the proportion of naive B cells was increased during fingolimod treatment in the peripheral blood (PB) of MS patients (p<0.05). The remaining T cell population, in contrast, showed elevated proportions of memory conventional and regulatory T cells (p<0.01) and declined proportions of naive conventional and regulatory cells (p<0.05). These naive T cell subtypes are main drivers of MS pathogenesis. B cell expression of CD80 and CD86 and programmed death (PD) -1 expression on circulating follicular helper T cells was increased during fingolimod follow-up (p<0.05) pointing to a potentially compensatory mechanism of the remaining circulating lymphocyte subtypes that could provide additional help during normal immune responses.MS patients treated with fingolimod showed a change in PB lymphocyte subtype proportions and expression of functional molecules on T and B cells, suggesting an association with the therapeutic efficacy of fingolimod." @default.
• W1984156843 created "2016-06-24" @default.
• W1984156843 creator A5004571174 @default.
• W1984156843 creator A5007805719 @default.
• W1984156843 creator A5026115175 @default.
• W1984156843 creator A5051450048 @default.
• W1984156843 creator A5065437335 @default.
• W1984156843 creator A5076078904 @default.
• W1984156843 creator A5082832005 @default.
• W1984156843 creator A5088390671 @default.
• W1984156843 creator A5091395853 @default.
• W1984156843 date "2014-10-31" @default.
• W1984156843 modified "2023-10-07" @default.
• W1984156843 title "Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study" @default.
• W1984156843 cites W1521119381 @default.
• W1984156843 cites W1586392520 @default.
• W1984156843 cites W1663253897 @default.
• W1984156843 cites W1934885234 @default.
• W1984156843 cites W1970480652 @default.
• W1984156843 cites W1978893911 @default.
• W1984156843 cites W1978928972 @default.
• W1984156843 cites W1986232616 @default.
• W1984156843 cites W2003551374 @default.
• W1984156843 cites W2019893382 @default.
• W1984156843 cites W2021310559 @default.
• W1984156843 cites W2026527347 @default.
• W1984156843 cites W2049063251 @default.
• W1984156843 cites W2051213845 @default.
• W1984156843 cites W2054226526 @default.
• W1984156843 cites W2054479200 @default.
• W1984156843 cites W2056366270 @default.
• W1984156843 cites W2057499294 @default.
• W1984156843 cites W2063223775 @default.
• W1984156843 cites W2075568217 @default.
• W1984156843 cites W2079246512 @default.
• W1984156843 cites W2089454752 @default.
• W1984156843 cites W2103477671 @default.
• W1984156843 cites W2104948944 @default.
• W1984156843 cites W2121929840 @default.
• W1984156843 cites W2126494959 @default.
• W1984156843 cites W2135746117 @default.
• W1984156843 cites W2137688247 @default.
• W1984156843 cites W2138854899 @default.
• W1984156843 cites W2151340435 @default.
• W1984156843 cites W2155245449 @default.
• W1984156843 cites W2159335325 @default.
• W1984156843 cites W2164250102 @default.
• W1984156843 cites W2167403404 @default.
• W1984156843 cites W2167876561 @default.
• W1984156843 cites W2916040650 @default.
• W1984156843 doi "https://doi.org/10.1371/journal.pone.0111115" @default.
• W1984156843 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4215872" @default.
• W1984156843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25360562" @default.
• W1984156843 hasPublicationYear "2014" @default.
• W1984156843 type Work @default.
• W1984156843 sameAs 1984156843 @default.
• W1984156843 citedByCount "72" @default.
• W1984156843 countsByYear W19841568432015 @default.
• W1984156843 countsByYear W19841568432016 @default.
• W1984156843 countsByYear W19841568432017 @default.
• W1984156843 countsByYear W19841568432018 @default.
• W1984156843 countsByYear W19841568432019 @default.
• W1984156843 countsByYear W19841568432020 @default.
• W1984156843 countsByYear W19841568432021 @default.
• W1984156843 countsByYear W19841568432022 @default.
• W1984156843 countsByYear W19841568432023 @default.
• W1984156843 crossrefType "journal-article" @default.
• W1984156843 hasAuthorship W1984156843A5004571174 @default.
• W1984156843 hasAuthorship W1984156843A5007805719 @default.
• W1984156843 hasAuthorship W1984156843A5026115175 @default.
• W1984156843 hasAuthorship W1984156843A5051450048 @default.
• W1984156843 hasAuthorship W1984156843A5065437335 @default.
• W1984156843 hasAuthorship W1984156843A5076078904 @default.
• W1984156843 hasAuthorship W1984156843A5082832005 @default.
• W1984156843 hasAuthorship W1984156843A5088390671 @default.
• W1984156843 hasAuthorship W1984156843A5091395853 @default.
• W1984156843 hasBestOaLocation W19841568431 @default.
• W1984156843 hasConcept C126322002 @default.
• W1984156843 hasConcept C154317977 @default.
• W1984156843 hasConcept C202751555 @default.
• W1984156843 hasConcept C203014093 @default.
• W1984156843 hasConcept C2776036978 @default.
• W1984156843 hasConcept C2776090121 @default.
• W1984156843 hasConcept C2778297628 @default.
• W1984156843 hasConcept C2780640218 @default.
• W1984156843 hasConcept C2780942790 @default.
• W1984156843 hasConcept C2781101188 @default.
• W1984156843 hasConcept C2908647359 @default.
• W1984156843 hasConcept C39347974 @default.
• W1984156843 hasConcept C55493867 @default.
• W1984156843 hasConcept C71924100 @default.
• W1984156843 hasConcept C86803240 @default.
• W1984156843 hasConcept C8891405 @default.
• W1984156843 hasConcept C99454951 @default.
• W1984156843 hasConceptScore W1984156843C126322002 @default.
• W1984156843 hasConceptScore W1984156843C154317977 @default.
• W1984156843 hasConceptScore W1984156843C202751555 @default.
• W1984156843 hasConceptScore W1984156843C203014093 @default.

• next